Efficacy and safety of Ranquilon® in the therapy of patients with anxiety associated with neurasthenia and adjustment disorder: results of the double-blind, randomized, placebo-controlled, multicenter phase 3 clinical trial

Efficacy and safety of Ranquilon® in the therapy of patients with anxiety associated with neurasthenia and adjustment disorder: results of the double-blind, randomized, placebo-controlled, multicenter phase 3 clinical trial

Objective: to evaluate the efficacy and safety of Ranquilon® (INN amide N-(6-phenylhexanoyl) glycyl-L-tryptophan)) tablets 1 mg2 at a dose of 6 mg per day (JSC “Valenta Pharm”, Russia) compared with placebo in the treatment of patients with anxiety in neurasthenia and adjustment disorder. Materialan...

Full description

Saved in:
Bibliographic Details
Main Authors: T. A. Karavayeva, E. M. Krupitsky, A. N. Barinov, L. G. Kolik, K. A. Ishchenko, K. K. Khacheva
Format: Article
Language:Russian
Published: Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2024-12-01
Series:Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:
anxiety states
neurasthenia
adjustment disorder
disorder of adaptive reactions
cholecystokinin system
ranquilon
Online Access:https://www.bekhterevreview.com/jour/article/view/1078
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items